NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

4.39  +0.79 (+21.94%)

After market: 3.92 -0.47 (-10.71%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to NLSP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 39.41% above the current price.
NLSP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NLSP.
In the previous month the buy percentage consensus was at a similar level.
NLSP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 4.396.066.126.126.30 - 38.04% 39.41% 39.41% 43.51%
Up and Down Grades
Date Firm Action Rating
2023-09-14 Maxim Group Downgrade Buy -> Hold
2022-12-08 Maxim Group Upgrade Hold -> Buy
2022-11-08 Maxim Group Downgrade Buy -> Hold
2022-09-06 Laidlaw & Co. Initiate Buy
2021-03-12 Brookline Capital Initiate Buy
2021-03-03 Maxim Group Initiate Buy